{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:02:07Z","timestamp":1777874527451,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jvoice.2026.03.019","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:12:38Z","timestamp":1776201158000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Dysphonia in Patients with Parkinson\u2019s Disease: A Scoping Review"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6467-4990","authenticated-orcid":false,"given":"Louis","family":"Abarca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-6165","authenticated-orcid":false,"given":"Priya","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-5456","authenticated-orcid":false,"given":"Julina","family":"Ongkasuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8336-4832","authenticated-orcid":false,"given":"Adam R.","family":"Szymanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2026.03.019_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","article-title":"Incidence of Parkinson disease in North America","volume":"8","author":"Willis","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.jvoice.2026.03.019_bib2","first-page":"9","article-title":"Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey","volume":"46","author":"Hartelius","year":"1994","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2026.03.019_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0892-1997(01)00010-8","article-title":"Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease","volume":"15","author":"Baumgartner","year":"2001","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib4","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1121\/1.397755","article-title":"Kinematic, acoustic, and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric adults","volume":"85","author":"Forrest","year":"1989","journal-title":"J Acoust Soc Am"},{"key":"10.1016\/j.jvoice.2026.03.019_bib5","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hbm.25790","article-title":"Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: randomized controlled trial","volume":"43","author":"Narayana","year":"2022","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.jvoice.2026.03.019_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/afj053","article-title":"Life with communication changes in Parkinson's disease","volume":"35","author":"Miller","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.jvoice.2026.03.019_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1353-8020(00)00079-1","article-title":"Longitudinal evaluation of economic and physical impact of Parkinson's disease","volume":"8","author":"Schenkman","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/01.mlg.0000232537.58310.22","article-title":"Clinical evaluation of Parkinson's-related dysphonia","volume":"116","author":"Sewall","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.03.019_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2014.08.003","article-title":"Depression and voice handicap in Parkinson disease","volume":"346","author":"Sunwoo","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jvoice.2026.03.019_bib10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1044\/jslhr.4205.1176","article-title":"Voice and speech characteristics of persons with Parkinson's disease pre- and post-pallidotomy surgery: preliminary findings","volume":"42","author":"Schulz","year":"1999","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2026.03.019_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0892-1997(99)80012-5","article-title":"Aerodynamic measurements of patients with Parkinson's disease","volume":"13","author":"Jiang","year":"1999","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib12","doi-asserted-by":"crossref","first-page":"e2124","DOI":"10.1212\/WNL.0000000000012878","article-title":"Defining speech subtypes in de novo Parkinson disease: response to long-term levodopa therapy","volume":"97","author":"Rusz","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2026.03.019_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13760-020-01486-0","article-title":"Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson's disease","volume":"121","author":"Koyuncu","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jvoice.2026.03.019_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jvoice.2026.03.019_bib15","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.jvoice.2026.03.019_bib16","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jvoice.2026.03.019_bib17","unstructured":"Wells G.A., Shea B., O\u2019Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"key":"10.1016\/j.jvoice.2026.03.019_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13682829209012034","article-title":"Can the Lombard effect be used to improve low voice intensity in Parkinson\u2019s disease?","volume":"27","author":"Adams","year":"1992","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000495837","article-title":"Spectral\/cepstral analyses of phonation in Parkinson's disease before and after voice treatment: a preliminary study","volume":"71","author":"Alharbi","year":"2019","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2026.03.019_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000525884","article-title":"An efficacy study of voice quality using cepstral analyses of phonation in Parkinson's disease before and after SPEAK-OUT!\u00ae","volume":"75","author":"Boutsen","year":"2023","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2026.03.019_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcomdis.2020.106031","article-title":"The impact of Lee Silverman Voice Treatment (LSVT LOUD\u00ae) on voice, communication, and participation: findings from a prospective, longitudinal study","volume":"89","author":"Bryans","year":"2021","journal-title":"J Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13682822.2010.484848","article-title":"Treating disordered speech and voice in Parkinson\u2019s disease online: a randomized controlled non-inferiority trial","volume":"46","author":"Constantinescu","year":"2011","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1590\/S0004-282X2003000100011","article-title":"Tratamento dos dist\u00darbios da voz na doen\u00c7a de Parkinson: o m\u00c9todo Lee Silverman","volume":"61","author":"Dias","year":"2003","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.jvoice.2026.03.019_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/13682829009011973","article-title":"Speech therapy and Parkinson\u2019s disease: a review and further data","volume":"25","author":"Johnson","year":"1990","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/17549507.2010.497559","article-title":"The effectiveness of traditional methods and altered auditory feedback in improving speech rate and intelligibility in speakers with Parkinson\u2019s disease","volume":"12","author":"Lowit","year":"2010","journal-title":"Int J Speech Lang Pathol"},{"key":"10.1016\/j.jvoice.2026.03.019_bib26","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1044\/jshr.3806.1232","article-title":"Comparison of two forms of intensive speech treatment for Parkinson disease","volume":"38","author":"Ramig","year":"1995","journal-title":"J Speech Lang Hear Res"},{"key":"10.1016\/j.jvoice.2026.03.019_bib27","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.47.6.1496","article-title":"Intensive speech treatment for patients with Parkinson\u2019s disease: short- and long-term comparison of two techniques","volume":"47","author":"Ramig","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2026.03.019_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H","article-title":"Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson\u2019s disease: a comparison with untreated patients and normal age-matched controls","volume":"16","author":"Ramig","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jnnp.71.4.493","article-title":"Intensive voice treatment (LSVT(R)) for patients with Parkinson\u2019s disease: a 2 year follow up","volume":"71","author":"Ramig","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2026.03.019_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/13682828409029837","article-title":"Speech therapy in Parkinson\u2019s disease: a study of the efficacy and long term effects of intensive treatment","volume":"19","author":"Robertson","year":"1984","journal-title":"Int J Lang Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40814-017-0222-z","article-title":"Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot)","volume":"4","author":"Sackley","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.jvoice.2026.03.019_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jnnp.46.2.140","article-title":"Speech therapy for Parkinson\u2019s disease","volume":"46","author":"Scott","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2026.03.019_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.parkreldis.2012.02.009","article-title":"Singing in groups for Parkinson\u2019s disease (SING-PD): a pilot study of group singing therapy for PD-related voice\/speech disorders","volume":"18","author":"Shih","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0892-1997(05)80210-3","article-title":"Intensive voice treatment in parkinson disease: laryngostroboscopic findings","volume":"9","author":"Smith","year":"1995","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib35","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1089\/tmj.2008.0040","article-title":"Videophone-delivered voice therapy: a comparative analysis of outcomes to traditional delivery for adults with Parkinson\u2019s disease","volume":"14","author":"Tindall","year":"2008","journal-title":"Telemed e-Health"},{"key":"10.1016\/j.jvoice.2026.03.019_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0022215122002031","article-title":"The effects of surface electrical stimulation plus voice therapy in Parkinson's disease","volume":"137","author":"Van Hooren","year":"2023","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2026.03.019_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clineuro.2007.04.003","article-title":"The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson\u2019s disease","volume":"109","author":"De Letter","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jvoice.2026.03.019_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9924(01)00072-7","article-title":"Phonatory characteristics of Parkinsonian speech before and after morning medication: the ON and OFF states","volume":"35","author":"Goberman","year":"2002","journal-title":"J Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jvoice.2018.04.002","article-title":"Voice quality and orofacial strength as outcome of levodopa effectiveness in patients with early idiopathic Parkinson disease: a preliminary report","volume":"33","author":"Lechien","year":"2019","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/231315a0","article-title":"Periodicity of speech in Parkinsonism","volume":"231","author":"Mawdsley","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.jvoice.2026.03.019_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.23.8.865","article-title":"Speech defects of Parkinsonian patients: effects of levodopa therapy on speech intelligibility","volume":"23","author":"Nakano","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2026.03.019_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0001-6918(98)00026-2","article-title":"Handwriting and speech changes across the levodopa cycle in Parkinson\u2019s disease","volume":"100","author":"Poluha","year":"1998","journal-title":"Acta Psychol"},{"key":"10.1016\/j.jvoice.2026.03.019_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1970.tb02111.x","article-title":"Speech changes in Parkinsonism during L-dopa therapy: preliminary findings","volume":"18","author":"Rigrodsky","year":"1970","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jvoice.2026.03.019_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002826-200103000-00006","article-title":"The effect of levodopa on vocal function in Parkinson\u2019s disease","volume":"24","author":"Sanabria","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jvoice.2026.03.019_bib45","first-page":"40","article-title":"Effect of Selegiline on speech performance in Parkinson\u2019s disease","volume":"45","author":"Shea","year":"1993","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2026.03.019_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9924(75)90019-2","article-title":"Speech changes in Parkinson\u2019s disease during treatment with L-DOPA","volume":"8","author":"Wolfe","year":"1975","journal-title":"J Commun Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jvoice.2006.10.010","article-title":"Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment","volume":"22","author":"D\u2019Alatri","year":"2008","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/neuros\/nyaa024","article-title":"Anterior sensorimotor subthalamic nucleus stimulation is associated with improved voice function","volume":"87","author":"Jorge","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jvoice.2026.03.019_bib49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jvoice.2011.03.006","article-title":"Digital voice analysis in patients with advanced Parkinson\u2019s disease undergoing deep brain stimulation therapy","volume":"26","author":"Mate","year":"2012","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jvoice.2018.10.012","article-title":"Dysphonia and dysarthria in people with Parkinson's disease after subthalamic nucleus deep brain stimulation: effect of frequency modulation","volume":"34","author":"Morello","year":"2020","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JPD-191798","article-title":"Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinson's disease patients: a 2-year prospective study","volume":"10","author":"Tanaka","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jvoice.2026.03.019_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.0b013e318203e7d0","article-title":"Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease","volume":"76","author":"Tripoliti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2026.03.019_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jnnp-2014-308043","article-title":"Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation","volume":"86","author":"Tsuboi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2026.03.019_bib54","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00702-017-1804-x","article-title":"Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study","volume":"124","author":"Tsuboi","year":"2017","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jvoice.2026.03.019_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jvoice.2010.08.002","article-title":"Changes in speech characters of patients with Parkinson\u2019s disease after bilateral subthalamic nucleus stimulation","volume":"25","author":"Xie","year":"2011","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2026.03.019_bib56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00005537-199908000-00020","article-title":"Treatment of Parkinson hypophonia with percutaneous collagen augmentation","volume":"109","author":"Berke","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.03.019_bib57","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/mds.10554","article-title":"Treatment of hypophonia with collagen vocal cord augmentation in patients with Parkinsonism","volume":"18","author":"Hill","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.jvoice.2026.03.019_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1067\/mhn.2002.125756","article-title":"Percutaneous laryngeal collagen augmentation for treatment of Parkinsonian hypophonia","volume":"126","author":"Kim","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2026.03.019_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.anorl.2016.07.005","article-title":"Reduction of Parkinson's-related dysphonia by thyroplasty","volume":"133","author":"Roubeau","year":"2016","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.jvoice.2026.03.019_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/S0004-282X2005000100004","article-title":"Acoustic voice assessment in Parkinson\u2019s disease patients submitted to posteroventral pallidotomy","volume":"63","author":"Mour\u00c3o","year":"2005","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.jvoice.2026.03.019_bib61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1044\/jslhr.4003.615","article-title":"Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease","volume":"40","author":"Baker","year":"1997","journal-title":"J Speech Lang Hear Res"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:56:47Z","timestamp":1777579007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199726001311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":61,"alternative-id":["S0892199726001311"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.03.019","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Dysphonia in Patients with Parkinson\u2019s Disease: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Voice Foundation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}